Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
24.73
+0.03 (+0.10%)
Streaming Delayed Price
Updated: 12:42 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 24, 2025
From
Pfizer Inc.
Via
Business Wire
Bill Gates Says 'Next Pandemic Can Emerge Anywhere' And The World Isn't Prepared: 'We Can't Afford To Get Caught Flat-Footed Again'
February 24, 2025
Via
Benzinga
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.’s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
February 24, 2025
From
Berger Montague
Via
GlobeNewswire
What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings
February 24, 2025
Specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) will be announcing earnings results tomorrow after market hours. Here’s what you need to know.
Via
StockStory
What's Driving the Market Sentiment Around Pfizer?
February 20, 2025
Via
Benzinga
3 Things You Need to Know If You Buy Pfizer Today
February 18, 2025
Via
The Motley Fool
Elanco (ELAN) Q4 Earnings Report Preview: What To Look For
February 24, 2025
Animal health company Elanco (NYSE:ELAN) will be announcing earnings results tomorrow before market open. Here’s what to look for.
Via
StockStory
Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect
February 24, 2025
Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings tomorrow after the bell. Here’s what to look for.
Via
StockStory
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
February 24, 2025
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.
Via
Benzinga
Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs
February 24, 2025
President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their manufacturing to the US or face the possibility of tariffs.
Via
Benzinga
Topics
Government
Exposures
Political
Market Monitor February 24th
February 24, 2025
Wall Street Slumps Amid Consumer Worries and New Virus Concerns from China
Via
Chartmill
Allogene Short Interest Reportedly Near 5-Year Lows Amid Growing Retail Optimism: Analyst Sees CAR-T Therapy Promise
February 23, 2025
Baird remains bullish on Allogene, stating that the updated cema-cel data continues to support the "differentiated durability" of its allogeneic CAR-T therapy.
Via
Stocktwits
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
February 23, 2025
These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.
Via
The Motley Fool
3 Ultra-High-Yield Dividend Stocks You Can Buy and Hold Forever
February 23, 2025
Via
The Motley Fool
3 Magnificent Dividend Growth Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade
February 22, 2025
Via
The Motley Fool
These S&P500 stocks are the most active in today's session
February 21, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Friday. Discover the stocks that are generating the highest...
Via
Chartmill
Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?
February 21, 2025
Exelixis reaffirmed its 2025 sales guidance of $2.15-$2.25 billion and reported sustained long-term efficacy for Cabometyx in advanced renal cell carcinoma.
Via
Benzinga
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
February 21, 2025
Pfizer has discontinued Beqvez for hemophilia B due to low patient demand and will focus on alternative treatments, including its approved therapy, Hympavzi.
Via
Benzinga
2 No-Brainer Healthcare Stocks to Buy With $500 Right Now
February 21, 2025
Via
The Motley Fool
Large Cap Biopharmaceutical Metrics And Performance Q1 2025
February 20, 2025
Tariffs could have big impact on earnings in 2025.
Via
Talk Markets
Topics
Stocks / Equities
Curious about the most active S&P500 stocks in today's session?
February 20, 2025
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via
Chartmill
The Smartest Dividend Stocks to Buy With $1,000 Right Now
February 20, 2025
Via
The Motley Fool
Which S&P500 stocks are the most active on Wednesday?
February 19, 2025
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via
Chartmill
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
February 19, 2025
Trump's proposed 25% tariffs on auto, semiconductor, and pharmaceutical imports have rattled markets and could affect ETFs with heavy exposure to these sectors.
Via
Benzinga
Topics
ETFs
Government
World Trade
Exposures
Political
Tariff
Rule Breaker Investing Stock Stories, Vol. 10: Frosty Campfire, Fiery Stocks
February 19, 2025
Every stock tells a story; it takes humans to find the meaning in it.
Via
The Motley Fool
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
February 19, 2025
Via
Benzinga
Love, Money, and Stocks
February 18, 2025
Via
The Motley Fool
Which S&P500 stocks are the most active on Tuesday?
February 18, 2025
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest...
Via
Chartmill
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.’s Board Of Directors For Breach of Fiduciary Duties (NYSE: PFE)
February 18, 2025
From
Berger Montague
Via
GlobeNewswire
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
February 18, 2025
Robert Reich has termed Donald Trump's taxation policies as an "absolutely shameless giveaway," that could shoot up deficit to $4.6 trillion.
Via
Benzinga
Topics
Government
Exposures
Political
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.